Transverse Myelitis Clinical Trials

Find Transverse Myelitis Clinical Trials Near You

Prospective Cohort Study of cLinical and Imaging Patterns of neUroinflammation disEases (CLUE)

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

CLUE is a prospective study to assess structural and functional changes of the brain, spinal cord, and optic nerve, as well as the inflammatory environment in patients with neuroinflammatory and demyelinating diseases. Participants will receive magnetic resonance (MR) techniques including DIR, DKI, QSM, Rs-fMRI, conventional sequences (T1WI/T2WI/FLAIR), and the MR metabolic SPICE sequence, and will be followed up for one year using 3T MRI. In addition, participants will receive a one-time baseline examination including T1WI, T2WI, FLAIR, and SWI sequences on 7T MRI, as well as PET-MRI.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Maximum Age: 75
Healthy Volunteers: t
View:

• 16-75

• Diagnosis of neuroinflammatory and demyelination disease

• Availability of demographic and clinical data at the time disease onset

• Informed written consent obtained from the patient, and/or patient's parent(s), and/or legal representative. Assent, if old enough to grant, will be obtained from all patients under the age of 16 years.

Locations
Other Locations
China
Beijing Tiantan Hospital
RECRUITING
Beijing
Contact Information
Primary
Yaou Liu, PhD
yaouliu80@163.com
+86 1059975396
Time Frame
Start Date: 2019-01-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 1000
Treatments
NMOSD
Patients with neuromyelitis optica spectrum disorders
Multiple sclerosis(MS)
Patients with multiple sclerosis
MOGAD
Patients with myelin oligodendrocyte glycoprotein antibody-associated disease
Healthy controls (HC)
Healthy people without any neuroinflammation disease
PACNS
primary angiitis of the central nervous system
AE
autoimmune encephalitis
Sponsors
Leads: Beijing Tiantan Hospital

This content was sourced from clinicaltrials.gov